Get In Touch
Xeraya Capital Sdn Bhd
26.03–26.08, G Tower
#199 Jalan Tun Razak, KL
xeraya@xeraya.com
+603 2381 8700
Submit a Proposal
proposal@xeraya.com
Back

News & Events

Latest news and events related to our activities and our portfolio partners.
  • Xeraya Admin
  • Posted by Xeraya Admin
September 24, 2020
4 min read

Chungnam National University Sejong Hospital Begins Patient Treatments with ViewRay's MRIdian Linac

  • Xeraya Admin
  • Posted by Xeraya Admin
September 15, 2020
7 min read

Exelixis and Iconic Therapeutics Announce Promising Preclinical Data that Support Best-In-Class Potential for ICON-2 in Treatment of Solid Tumors

  • Xeraya Admin
  • Posted by Xeraya Admin
September 8, 2020
5 min read

Acutus Medical Announces Pulse Field Ablation Program and Initial Pre-Clinical Results

  • Xeraya Admin
  • Posted by Xeraya Admin
August 27, 2020
5 min read

ViewRay, GenesisCare and the University of Oxford Announce Groundbreaking Compassionate Access Programme Now Open to UK Patients with Localized Pancreatic Cancer

  • Xeraya Admin
  • Posted by Xeraya Admin
August 10, 2020
3 min read

Acutus Medical Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

  • Xeraya Admin
  • Posted by Xeraya Admin
August 6, 2020
3 min read

Heart-mapping Acutus Medical kicks off $158M Nasdaq IPO

  • Xeraya Admin
  • Posted by Xeraya Admin
July 30, 2020
5 min read

Imago BioSciences Granted Access by European Medicines Agency to PRIME Scheme for IMG-7289 (Bomedemstat) in Myelofibrosis

  • Xeraya Admin
  • Posted by Xeraya Admin
July 17, 2020
13 min read

Imago Biosciences: Experimental Treatment for Rare Bone Cancer Shows Promise in Phase 2 Study

  • Xeraya Admin
  • Posted by Xeraya Admin
July 16, 2020
6 min read

GreenLight Biosciences supercharges its efforts with $102M Series D funding from top-tier investors including Morningside Ventures, S2G Ventures and Lupa Systems

  • Xeraya Admin
  • Posted by Xeraya Admin
June 2, 2020
7 min read

LanzaJet Takes Off: Innovative Sustainable Fuel Technology and Investment Structure to Accelerate Commercialization, Regional Job Growth, and Carbon Reduction

  • Xeraya Admin
  • Posted by Xeraya Admin
May 27, 2020
5 min read

Rapid Micro Biosystems Raises $120 Million to Accelerate Global Expansion of Contaminant Testing Platform for Pharmaceutical and Vaccine Manufacturing

  • Xeraya Admin
  • Posted by Xeraya Admin
May 27, 2020
3 min read

Providence Portland Medical Center Begins Patient Treatments with ViewRay's MRIdian Linac

  • Xeraya Admin
  • Posted by Xeraya Admin
May 26, 2020
3 min read

Partnership to provide catheter-based treatment products for cardiac arrhythmias

  • Xeraya Admin
  • Posted by Xeraya Admin
May 26, 2020
3 min read

Imago BioSciences To Present Update on Phase 2 results of Bomedemstat (IMG-7289), a Lysine Specific Demethylase-1 (LSD1) Inhibitor for the Treatment of Myelofibrosis (MF)

  • Xeraya Admin
  • Posted by Xeraya Admin
May 18, 2020
5 min read

Liquidia Appoints Tushar Shah, M.D., as Chief Medical Officer

  • Xeraya Admin
  • Posted by Xeraya Admin
May 12, 2020
5 min read

GreenLight Biosciences raises $17M financing round to accelerate large-scale manufacturing of future COVID-19 vaccines

  • Xeraya Admin
  • Posted by Xeraya Admin
May 12, 2020
9 min read

OptiScan Biomedical Receives CE Mark for OptiScanner 7000 for Automated Multivariate Monitoring of Metabolic and Hemodynamic Status of Patients in the Intensive Care Unit

  • Xeraya Admin
  • Posted by Xeraya Admin
May 1, 2020
8 min read

Agtech startup Pivot Bio snags $100m amid busy April for climate tech

  • Xeraya Admin
  • Posted by Xeraya Admin
April 22, 2020
4 min read

Imago BioSciences Appoints Bob Baltera to Board of Directors

  • Xeraya Admin
  • Posted by Xeraya Admin
April 8, 2020
4 min read

Liquidia Announces FDA Acceptance of New Drug Application for LIQ861 (treprostinil) Inhalation Powder for the Treatment of Pulmonary Arterial Hypertension

  • Xeraya Admin
  • Posted by Xeraya Admin
April 1, 2020
4 min read

ViewRay and VieCure Announce Strategic Collaboration to Accelerate Adoption of Personalized Cancer Care

  • Xeraya Admin
  • Posted by Xeraya Admin
March 30, 2020
3 min read

P2 and Bedoukian Research Announce Joint Development in Pheromones

  • Xeraya Admin
  • Posted by Xeraya Admin
February 25, 2020
4 min read

Aria CV Announces $31 Million in Series B Funding

  • Xeraya Admin
  • Posted by Xeraya Admin
February 25, 2020
7 min read

Allecra Therapeutics Announces Positive Top-Line Results for Phase 3 ALLIUM Clinical Trial of EXBLIFEP(R) for Complicated Urinary Tract Infections